Results 181 to 190 of about 185,181 (328)

Mechanism of exacerbation of traumatic brain injury under warfarin anticoagulation in male mice.

PLoS ONE
IntroductionTraumatic brain injury (TBI) is exacerbated in patients on antithrombotic medications, with warfarin leading to increased bleeding in some cases.
Yuki Tatara, Ken-Ichiro Nakao, Ryo Shimada, Kazuhiko Kibayashi   +3 more
doaj   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more

Pharmacy Practice, 2012
In Estonia, warfarin is widely prescribed by general practitioners to prevent and treat thromboembolic diseases. To date, there has been no systematic analysis of the potential risk of warfarin interactions with other drugs in the outpatient population ...
Gavronski M, Hartikainen S, Zharkovsky A, Sautenkova N   +3 more
doaj  

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

Clinical pharmacology and therapy, 2017
Julie A. Johnson, K. Caudle, L. Gong, Michelle Whirl‐Carrillo, C. Stein, S. Scott, M. M. Lee, B. Gage, S. Kimmel, M. Perera, Jeffrey L. Anderson, M. Pirmohamed, T. Klein, N. Limdi, L. Cavallari, M. Wadelius   +15 more
semanticscholar   +1 more source

Efficacy of pro‐haemostatic agents in the management of factor Xa inhibitor‐associated intracranial haemorrhages

Internal Medicine Journal, EarlyView.
Abstract Background An increasing number of patients in Australia are taking direct oral anticoagulants for a variety of indications since their introduction in the treatment landscape. There has always been some concern about the optimal management approach in the setting of major and/or life‐threatening bleeding.
Sara Shu‐Ling Ng, Hashim Noori, Diem Nguyen, Zhengbang Wang, Danny Hsu   +4 more
wiley   +1 more source

Medicinal cannabis: is current use clinically justified?

Internal Medicine Journal, EarlyView.
Abstract Cannabis products are increasingly perceived and advertised as natural and safe treatments for a variety of conditions, including chronic non‐cancer pain (CNCP). The number of prescriptions for medicinal cannabis (MC) currently averages >80 000 per month for >1 million Australians. Although over 800 different cannabis products are available to
Russ J. Scott, Ian A. Scott
wiley   +1 more source

2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri‐operative and bleeding management

Internal Medicine Journal, EarlyView.
Abstract Direct oral anticoagulants (DOACs) are widely prescribed to prevent and treat venous and arterial thromboembolism, supported by published evidence, and are preferred over warfarin in many guidelines. Although the risk of major bleeding, in particular intracranial haemorrhage (ICH), is decreased with DOACs, gastrointestinal bleeding is ...
Huyen A. Tran, Eileen Merriman, Ross Baker, Jennifer Curnow, Laura Young, Chee Wee Tan, Simon McRae, Sanjeev D. Chunilal   +7 more
wiley   +1 more source

INTERACTIONS WITH WARFARIN [PDF]

British Journal of Clinical Pharmacology, 1974
openaire   +3 more sources

Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT This state‐of‐the‐art review is based on the Philippe Coumel Lecture in 2024 (Figure 1). It highlights the confluence of two major cardiovascular epidemics, atrial fibrillation and heart failure, with preserved ejection fraction. In these conditions, advances in electrophysiology and heart failure physiology are intertwined and are integrated ...
Sanjeev Saksena, April Slee, Ranghadham Nagarakanti, Atul Prakash   +3 more
wiley   +1 more source

Genome‐Wide Association Study of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation in a Japanese Population

Journal of Cardiovascular Electrophysiology, EarlyView.
This study aimed to identify the factors associated with atrial fibrillation (AF) recurrence after catheter ablation. The clinical information analysis revealed persistent AF, nonpulmonary AF triggers, NT‐proBNP levels, and the left atrial volume were clinical predictors of recurrence.
Takumi Sakai, Motoki Furutani, Mika Nakashima, Naoki Ishibashi, Junji Maeda, Naoto Oguri, Shogo Miyamoto, Shunsuke Miyauchi, Sho Okamura, Yousaku Okubo, Takehito Tokuyama, Noboru Oda, Risa Mitsumori, Shumpei Niida, Kouichi Ozaki, Daichi Shigemizu, Yukiko Nakano   +16 more
wiley   +1 more source